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INTRODUCTION
Autoimmune hepatitis (AIH) is characterized by chronic
necro-inflammation of the liver of unknown cause, in which
immune reactions against host antigens are found to be the
major pathologic mechanism. Autoimmune hepatitis can
be associated with a number of other autoimmune diseases
(1). Liver involvement, except hepatomegaly, is rare in
patients with mixed connective tissue disease (MCTD) or
Sjogren’ s syndrome (SS). Only two cases of AIH associated
with MCTD and SS have been reported in the literature (2,
3). The clinical features of autoimmune hepatitis vary from
asymptomatic, in which the disease is discovered when
abnormal serum enzyme levels are detected during a screen-
ing examination, to a severe, acute, and even fulminant
hepatitis (4). Cholestatic liver dysfunction is a rare clinical
manifestation of AIH. Unlike primary biliary cirrhosis and
sclerosing cholangitis, AIH responds favorably to steroid
therapy (5). 
We describe a patient with MCTD and SS presenting
with severe cholestatic AIH and acute liver failure, whose
liver function abnormalities resolved after steroid therapy. 
CASE REPORT
A 40-yr-old woman was admitted to the hospital because
of progressive jaundice over two months. Two years before
admission, the patient was diagnosed to have an overlap
syndrome of MCTD and SS. The diagnosis of MCTD was
made by the presence of high titer of anti-ribonucleoprotein
antibodies, edema of both hands, synovitis, Raynaud’ s phe-
nomenon, and acrosclerosis. Sjogren’ s syndrome was diag-
nosed by the presence of dry mouth, dry eyes, rheumatoid
factor, anti-Ro antibodies, positive results of a Schirmer’ s
test, salivary scintigraphy, and labial salivary gland biopsy.
She had been intermittently treated with prednisolone (10
mg/day), but had not taken any medications during the pre-
vious three months. She denied ethanol ingestion and recent
use of hepatotoxic drugs. 
On physical examination, the patient appeared acutely ill.
Her temperature was 37℃, pulse rate 108/min, respiration
rate 26/min and blood pressure was 110/70 mmHg. Ane-
mic conjunctiva and icteric sclera were observed. Ausculta-
tion of the heart and both lungs were normal. The abdomen
was soft with normal bowel sounds. The edge of the liver
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A Case of Cholestatic Autoimmune Hepatitis and Acute Liver Failure:
an Unusual Hepatic Manifestation of Mixed Connective Tissue Disease
and Sjogren's Syndrome
Although hepatomegaly is reported to occur occasionally in patients with mixed
connective tissue disease (MCTD) or Sjogren’ s syndrome (SS), autoimmune
liver diseases such as primary biliary cirrhosis, sclerosing cholangitis, and
autoimmune hepatitis in association with MCTD or SS have rarely been
described. We report a case of severe cholestatic autoimmune hepatitis pre-
senting with acute liver failure in a 40-yr-old female patient suffering from MCTD
and SS. The diagnosis of MCTD and SS was made at the age of 38. The
patient presented severe jaundice and elevation of conjugated bilirubin. The
patient denied alcohol and drug use and had no evidence of viral hepatitis. On
the 8th day of her hospitalization, the patient developed grade III hepatic
encephalopathy. She was diagnosed as autoimmune hepatitis presenting with
acute liver failure based on clinical features, positive FANA and anti-smooth
muscle antibodies, negative anti-mitochondrial antibodies, high titers of serum
globulin, liver biopsy findings, and a good response to corticosteroid therapy,
The patient was managed with prednisolone and the clinical symptoms, liver
function test results, and liver biopsy findings showed much improvement after
steroid therapy.
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Fig. 1. The initial needle aspirated biopsy specimen of the liver on the 19th hospital day show; (A) piecemeal necrosis, bridging necrosis,
hepatocellular necrosis, cholestasis in the hepatocyte with bile ductule proliferation and moderate infiltration of chronic inflammatory cells
in the portal area and (B) bridging fibrosis (A: H&E, ×100; B: Masson-Trichrome, ×40).
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Fig. 2. The follow-up liver biopsy after treatment with steroids for seven months revealed improved histologic findings (A: H&E, ×100;
B: Masson-Trichrome, ×40).
descended 2.5 cm below the right costal margin. 
Her initial laboratory findings were as follows: hemat-
ocrit 25.1%, leukocyte count 18,400/ L (33.7% neu-
trophils, 57.2% lymphocytes, 5.9% monocytes, 3.1%
basophils), platelet count 151,000/ L, glucose 125 mg/dL,
urea nitrogen 14.0 mg/dL, creatinine 1.5 mg/dL, total
serum protein 8.1 g/dL, albumin 2.3 g/dL, aspartate amino-
transferase 383 IU/L, alanine aminotransferase 149 IU/L,
total bilirubin 26 mg/dL, conjugated bilirubin 25.3 mg/dL,
alkaline phosphatase 164 U/L, LDH 1,316 IU/L,  -GTP
63.0 U/L, total cholesterol 61.0 mg/dL, calcium 7.8 mg/dL,
phosphorus 2.6 mg/dL, and haptoglobin 20.7 mg/dL. Test
results for sodium, potassium, chloride, magnesium, and
triglyceride were all within normal limits. International
normalized ratio for prothrombin time was 1.25, and the
activated partial thromboplastin time was 46.4 sec. The
patient’ s reticulocyte count was 4.4%. Direct Coombs test
was positive, while an indirect Coombs test was negative.
The concentrations of IgG, IgA, and IgM were 4,630
mg/dL, 397 mg/dL, and 311 mg/dL, respectively. Serum
electrophoresis showed polyclonal gammopathy. The serum
circulating immune complex was 1.39  g/mL (normal
<1.23  g/mL), C3 26 mg/dL (normal 50-90), and C4 10
mg/dL (normal 10-40). A test for anti-nuclear antibodies
was positive, at a titer of 1:2,560, with a speckled pattern of
staining. Tests for the rheumatoid factor, anti-RNP, anti-
SSA, and anti-smooth muscle antibodies were all positive.
Tests for antibodies to ds DNA, Sm, SSB, mitochondria,
liver-kidney microsome, platelets, cardiolipin antibodies,
and lupus anticoagulant were all negative. A test for hepati-
tis A IgG antibodies was positive. Tests for hepatitis A IgM
antibodies, hepatitis B surface antigen and antibody, hepati-
tis C IgG antibodies and cytomegalovirus antibodies were
all negative. Tests for antibodies to the Epstein-Barr nuclear
antigen and viral capsid antigen (IgG) were both positive.
Urinalysis was normal, except for positive results for uro-
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bilinogen and bilirubin. 
A radiography of the abdomen demonstrated an ileus on
the periumbilical area. An abdominal ultrasonographic
examination showed mild hepatosplenomegaly, small
amounts of ascites, no dilatation of the bile ducts, and no
masses. A liver scan disclosed a very inhomogeneous and
lobulated contour of the liver and splenomegaly with high
splenic activity. Endoscopic retrograde cholangiopancre-
atography performed on the fourth hospital day demon-
strated no abnormalities of the bile ducts. Prednisolone (30
mg/day) was administered beginning on the fifth hospital
day, on the presumptive diagnosis of AIH. 
On 8th day of her hospitalization, the patient developed
grade III hepatic encephalopathy. She was treated with
intravenous methylprednisolone (62.5 mg/day) for three
days. Her encephalopathy improved with intravenous
steroid administration along with conservative manage-
ment for hepatic encephalopathy. Intravenous steroid injec-
tions were changed to oral prednisolone 50 mg (1 mg/
kg/day), and then slowly tapered. A needle aspirated liver
biopsy was undertaken on the 19th hospital day. Histology
showed moderate piecemeal necrosis, bridging necrosis,
moderate hepatocellular necrosis, mild cholestasis in the
hepatocytes with mild bile duct proliferation in the portal
area, moderate infiltration of chronic inflammatory cells in
the portal area and bridging fibrosis (Fig. 1). Follow-up
needle aspirated liver biopsy at seven months of steroid
therapy demonstrated improved histologic findings with
focal hepatocellular necrosis, mild infiltration of chronic
inflammatory cells in the portal area and fibrous portal
expansion (Fig. 2). The patient’ s elevated bilirubin level
began to decline after the administration of steroids for 20
days (Fig. 3), and eventually normalized in five months. She
is now managed with prednisolone 5 mg/day.  
DISCUSSION
We described a patient with overlap syndrome of MCTD
and SS presenting with severe cholestatic autoimmune hep-
atitis and acute liver failure, whose jaundice and abnormal
liver function test results resolved following steroid therapy.
Mixed connective tissue disease is an overlap syndrome com-
bining features of systemic lupus erythematosus, systemic
sclerosis and polymyositis, together with the presence of
antibodies to U1 RNP. SS is an autoimmune exocrinopathy
in which the exocrine tissues are invaded by immune cells.
The differential diagnosis of cholestatic liver disease includes
various etiologies (6). In our patient, there was no evidence of
extrahepatic obstruction or biliary tract stricture on imaging
studies, and no drug history that may cause cholestasis. These
initial findings led us to consider autoimmune liver diseases
including primary biliary cirrhosis (PBC), sclerosing cholan-
gitis, AIH and autoimmune cholangitis to explain the liver
problems in our patient. The final diagnosis of AIH was
made on the basis of positive FANA and anti-smooth mus-
cle antibody testing, high titers of serum globulin, no evi-
dence of current hepatitis virus infection, histologic find-
ings, and a good response to corticosteroid therapy, all of
which met the diagnostic criteria for AIH proposed by the
International Autoimmune Hepatitis Group (7). Generally,
the elevations in serum aminotransferase levels are more
striking than the elevations of bilirubin or alkaline phos-
phatase, but the profound cholestatic liver dysfunction in
our patient was an unusual manifestation of AIH. There are
two conditions in which the features of both AIH and PBC,
which usually shows the clinical manifestations of cholestat-
ic liver disease, occur; overlap syndrome and autoimmune
cholangitis (1). In overlap syndrome, the histologic findings
of AIH are accompanied by the presence of the antimito-
chondrial antibody that is a characteristic serologic findings
of PBC. In autoimmune cholangitis, the histologic features
of both AIH and PBC may be present. These two condi-
tions can be excluded through liver biopsy and by the
absence of antimitochondrial antibodies. It is important to
distinguish AIH from viral hepatitis, especially hepatitis C.
Hepatitis C often has similar clinicolaboratory and patho-
logic findings with AIH (8). Negative results of repeated
tests for anti-HCV antibody and a good response to steroid
therapy excluded the possibility of HCV infection in our
patient.
Although hepatomegaly is sometimes observed in
MCTD patients, a few cases of AIH associated with MCTD
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Fig. 3. Clinical course and follow-up laboratory findings.
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have been reported (2, 3, 9-13). HLA-DR4 has been report-
ed to be related to AIH and MCTD (13). However, HLA
typing was not performed in our patient.
Liver involvement in SS patients is rare and subclinical
with histological features predominantly of stage I PBC
(14). The association of AIH with MCTD and SS is
extremely rare. Only two cases of AIH, MCTD and SS have
previously been described (2, 3).
AIH can be categorized into three subtypes based on
immunoserologic findings (1). In this case, positive antinu-
clear antibodies, anti-smooth muscle antibodies, negative
anti-mitochondrial antibodies and anti-LKM antibodies
suggested that the patient had type I AIH. In addition to
cholestatic manifestations, acute liver failure was also an
unusual initial presentation of AIH in this case. Acute liver
failure has seldom been reported in a patient with AIH type
I (15).
The laboratory findings of a positive direct Coombs test,
increased levels of reticulocyte counts, serum LDH, and
serum unconjugated bilirubin, increased urine urobilino-
gen, and a decreased serum haptoglobin level in our patient
were all compatible with the features in autoimmune
hemolytic anemia. And, autoimmune hemolytic anemia has
been considered to be one of the disorders associated with
AIH (1).
Glucocorticoid therapy remains the mainstay of therapy
for AIH. Combining this treatment with azathioprine is
sometimes preferred by physicians because it is associated
with fewer side effects than higher dose prednisolone alone
(5). Generally, a biochemical response occurs within one to
three months after the initiation of treatment, although
remission has been reported in a very small percentage of
patients even after years of treatment. In our case, serum
bilirubin level began to decline after 20 days of steroid ther-
apy, and to be normalized in five months. In patients with
AIH who experience spontaneous or pharmacologically
induced remission, the histologic findings may revert to
inflammation confined to the portal areas or to inactive cir-
rhosis, if cirrhosis has already been established (1). In our
patient, the initial liver biopsy on the 19th hospital day
showed moderate hepatocellular necrosis and bridging
fibrosis. The follow-up liver biopsy in the state of remission
revealed an improvement of the disease activity with focal
hepatocellular necrosis and fibrous portal expansion. To our
knowledge, this is the first case report of MCTD and SS
associated with cholestatic AIH and acute liver failure, in
which clinical remission and histological improvement
were observed with steroid therapy.
In summary, cholestatic AIH can be associated with
MCTD and SS, and usually responds well to steroid thera-
py. However, other cholestatic disorders with immunologic
features, such as PBC and sclerosing cholangitis, are resis-
tant to steroid treatment. Therefore, it is important to
include AIH in the differential diagnosis of patients with
MCTD and SS who also exhibit cholestatic hepatopathy.
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